DE   EN   ES   FR   IT   PT


medicalmeds.eu Medicines Nootropic means. Tserepro

Tserepro

Препарат Церепро. УП «Минскинтеркапс» Республика Беларусь


Producer: Minskinterkaps Unitary Enterprise Republic of Belarus

Code of automatic telephone exchange: N07AX02

Release form: Firm dosage forms. Capsules.

Indications to use: Craniocereberal injury. Ischemic stroke. Hemorrhagic stroke. Psychoorganic syndrome. Disturbance of cerebral circulation. Cognitive frustration. Dementia. Encephalopathy.


General characteristics. Structure:

Active ingredient: 400 mg of a glitserilfosforilkholin of hydrate (sincaline of an alfostserat).

Excipients: глицерол, the water purified.

Structure of a cover of the capsule: gelatin, глицерол, sorbitol of 70% solution, the water purified нипагин, нипазол, titanium dioxide, dye ferrous oxide red (E172).

The drug improving behavioural, cognitive reactions, normalizing bioelectric activity of a brain, involution of a psychoorganic syndrome at patients during the posttraumatic period and with vascular pathologies of a brain.




Pharmacological properties:

Pharmacodynamics. The central holinostimulyator as a part of which 40,5% of metabolic protected sincaline contain (metabolic protection provides release of sincaline in a brain). At hit in an organism it is split under the influence of enzymes on sincaline and glycerophosphate: sincaline participates in biosynthesis of acetylcholine – one of the main mediators of nervous excitement; glycerophosphate is a predecessor of phospholipids (fosfaditilkholin) of a neural membrane. Provides synthesis of acetylcholine and fosfaditilkholin in neyronalny membranes, improves a blood stream and strengthens metabolic processes in the central nervous system, activates a reticular formation. Increases the linear speed of a blood-groove on the party of traumatic damage of a brain, contributes to normalization of spatio-temporal characteristics of spontaneous bioelectric activity of a brain; exerts positive impact on cognitive and behavioural reactions of patients with vascular diseases of a brain.

Improves functions of a brain, influencing pathogenetic factors of an involutional psychoorganic syndrome, changes phospholipidic structure of membranes of neurons and reduces cholinergic activity. Dozozavisimo stimulates allocation of acetylcholine; participating in phosphatidylsincaline synthesis (membrane phospholipid), improves synoptic transfer, plasticity of neyronalny membranes, function of receptors. Does not exert impact on a reproductive cycle and does not possess teratogenic and mutagen action.

Pharmacokinetics. Absorption – 88%, easily gets through a blood-brain barrier (at oral administration concentration in a brain – 45% of that in plasma). It is removed preferential easy, in the form of carbon dioxide (85%), and also kidneys and through intestines (15%).


Indications to use:

- the acute and recovery periods of a severe craniocereberal injury and ischemic stroke, the recovery period of a hemorrhagic stroke proceeding with focal polusharny symptomatology or symptoms of defeat of a brainstem;

- a psychoorganic syndrome against the background of degenerative and involutional changes of a brain;

- chronic insufficiency of cerebral circulation;

- cognitive frustration (disturbance of cogitative function, memory, confusion of consciousness, a disorientation, decrease in motivation, initiative and ability of concentration of attention) including at dementia and encephalopathy;

- senile pseudo-melancholy.


Route of administration and doses:

At acute states: inside on 0,8 g (2 capsules) in the morning and 0,4 g (1 capsule) in the afternoon within 6 months.

At chronicities: inside on 0,4 g (1 capsule) 3 times a day, are preferable to food. Duration of treatment makes 3-6 months.


Features of use:

When developing nausea after administration of drug it is necessary to reduce a dose.

Not influence on a possibility of driving of the car, work with the equipment.


Side effects:

Allergic reactions, nausea (owing to dopaminergic activation).


Interaction with other medicines:

It is not revealed.


Contraindications:

- hypersensitivity;

- pregnancy;

- lactation period.


Overdose:

Symptoms: dyspepsia.

Treatment: gastric lavage, reception of absorbent carbon, symptomatic therapy.


Storage conditions:

Drug should be stored in unavailable to children, protected from moisture and light and the place at a temperature not above 25 °C. Period of validity 2 years.


Issue conditions:

According to the recipe


Packaging:

On 14 capsules in a blister strip packaging, 1 strip packaging in a cardboard box.



Similar drugs

Препарат Делецит. УП «Минскинтеркапс» Республика Беларусь

Deletsit

Nootropic means.



Препарат Церетон®. УП «Минскинтеркапс» Республика Беларусь

Церетон®

Nootropic means.



Препарат Глиатилин. УП «Минскинтеркапс» Республика Беларусь

Gliatilin

Nootropic drugs.



Препарат Холитилин®. УП «Минскинтеркапс» Республика Беларусь

Холитилин®

Nootropic means.



Препарат Церепро. УП «Минскинтеркапс» Республика Беларусь

Tserepro

Nootropic drugs.



Препарат Церепро. УП «Минскинтеркапс» Республика Беларусь

Tserepro

Nootropic drugs.



Препарат Делецит 400. УП «Минскинтеркапс» Республика Беларусь

Deletsit 40

Nootropic means.



Препарат Церетон®. УП «Минскинтеркапс» Республика Беларусь

Церетон®

Nootropic means.



Препарат Делецит 1000. УП «Минскинтеркапс» Республика Беларусь

Deletsit 100

Nootropic means.





  • Сайт детского здоровья